Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Effective anti-inflammatory agents but doubts about safety remain
| The first 150 words of the full text of this article appear below. |
The millennium brings with it the 50th anniversary of Hench's discovery that corticosteroids might be used to treat rheumatoid arthritis.1 Attitudes towards such use have waxed and waned since then. Initial hope that steroids might dramatically alter the long term course of the disorder gave way to a recognition of the serious adverse effects that accompany high dose treatment. As a result the use of low dose corticosteroids in arthritis remains highly controversial.
Corticosteroids are used widely in medicine today. A recent survey in
general practice found that 1.4% of patients aged over 54 were using
corticosteroids at a mean dose of 8 mg daily2: rheumatoid
arthritis was the indication in 23% of cases. Although rheumatologists
claim to use steroids relatively infrequently, audits of patients
attending outpatient departments suggest a high prevalence of use (as
great as 80%).
3 4
What, then, is the quality of the
evidence to support the use of